Bioclinic Naturals are excited to announce a ground-breaking 5-year research collaboration with Macquarie University, which will build on the Scobiotic™ novel IP, pertaining to host and microbiome interactions.

The research partnership will focus on restoration of normal microbiomes in gut issues such as IBS, examining and utilising the synergistic effects of the host, the host microbiome and Scobiotics™ (revolutionary, syntrophic mixed cultures of living organisms, prebiotics and substrates) by identifying the best combinations to achieve homeostasis. Macquarie University’s new ARC Training Centre for Facilitated Advancement of Australia’s Bioactives (FAAB) will bring together industry leading Bioclinic Naturals with Macquarie University, Deakin University, the University of Australia and Western Sydney University with research universities in the UK, Germany and Brazil to research products of high molecular complexity that can relieve chronic and acute health problems. The research with Bioclinic Naturals is a pillar project for the facility. FAAB’s leadership team consist of training centre Director Professor Alison Rodger – who was recently made a Fellow of the Australian Academy of Science, Partnerships Director Professor Anwar Sunna and Research Director Dr Alfonso Garcia-Bennett. Partnerships Director for the Facilitated Advancement of Australia’s Bioactives (FAAB), Professor Anwar Sunna says of the partnership: “We are excited to be entering into this partnership with Bioclinic Naturals, to apply advanced analytical methods to determine modes of action for bioactives with potential lifestyle and nutritional benefits. This partnership will provide support for training the next generation of industry-embedded experts and creation of new high-skilled jobs for FAAB graduates.”

Download Full Article Here

Categories: News